Sure, but just to be clear, by that time, and we're talking about probably in 10 to 15 years, it will have gone through a very rigorous testing process in labs where you use probably rats, but also then you have to go through clinical trials. There are three different phases of clinical trials in human beings to make sure these drugs are absolutely safe and efficacious for patients. Only then do you get approval from Health Canada. At that point in time, you then have a product that can actually be used for patients.
I wouldn't consider that to be experimental at that point, because by then you've done all the work on it, and you've made sure it's actually going to work and be safe for patients. Then you're talking about a novel therapy, in which case, yes, because it's addressing an unmet need. Obviously, it's addressing an affliction of a patient who is suffering. It could save a life, so, yes, any sort of pharmacare program should cover that therapy.